Excelitas Technologies Announces Agreement to Acquire Axsun Technologies
Excelitas expands portfolio of high performance photonics solutions serving the Medical and Industrial markets.
WALTHAM, Mass., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Excelitas Technologies® Corp., a global technology leader focused on delivering innovative, customized photonic solutions, today announced that it has signed a definitive agreement to acquire Axsun Technologies (Billerica, MA USA). Axsun is a privately-held company specializing in the development and production of innovative, MEMS-based light engines for high performance medical imaging and industrial spectroscopy applications.
Terms of the agreement are not being disclosed and the transaction is expected to close in early 2019.
For more information on Excelitas, visit www.excelitas.com
About Excelitas Technologies
Excelitas Technologies Corp. is a global technology leader focused on delivering innovative, high-performance, market-driven photonic solutions to meet the lighting, detection and optical technology needs of global customers. From biomedical technology to research laboratory, safety and security, consumer products, semiconductor, energy and environment, industrial sensing & imaging, defense and aerospace, Excelitas Technologies is committed to enabling our customers' success in their end markets. Excelitas Technologies now has approximately 6700 employees in North America, Europe and Asia, serving customers across the world. Connect with Excelitas on Facebook, LinkedIn and Twitter.
Contacts:
Scott Orr
Senior Director of Global Marketing - Commercial
scott.orr@excelitas.com
781.996.5925
Cheryl Reynhout or Jill Anderson
On Behalf of Excelitas Technologies Corp.
SVM Public Relations
excelitas@svmmarcom.com
401.490.9700
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
